Syngene International Ltd IPO Message Board (Page 2)

Loading...
Chem cho
276. Chem cho  Aug 11, 2015 10:57
IPO Guru IPO Guru (2100+ Posts, 2100+ Likes)
sold at rs 310*60 . 309*60 . 308*60 , 306*60

total sold 240 shares

this share cannot go higher than BICON so watch out bicon rate and trade for syngene
patel patel
276.1. patel patel  Aug 11, 2015 11:08
GOOD LUCK
patel patel
275. patel patel  Aug 11, 2015 10:51
syngene 60 share sell rs:299 ma
bangalore king
274. bangalore king  Aug 11, 2015 10:47
Top Contributor Top Contributor (400+ Posts)
Dont sell Syngene.. keep for long term ! It deserves scarcity premium.

Here is brand new motilal oswal report on that -

Initiating Coverage Buy Rs. 285

We recommend a BUY on Syngene International with a target
of INR 350- valuing the company at 25x FY 17E EPS.

Unique CRO play: Syngene, subsidiary of Biocon, is a contract
research organisations (CRO) with 2000+ scientists working for 16 of
the top -20 global innovators. Syngene offers integrated discovery and
development services to over 211 clients globally (103 in CY12) in
pharma, biotech, agrochemical and other industries. Long-standing
relationships with customers have been a key strength. Some of its
strategic collaborations are with Bristol - Myers Squibb, Baxter, Endo
Pharmaceuticals (pharma), and Abbott Nutrition.

Valuations & View: We recommend buying Syngene post the listing
for a target price of INR 350 per share. We value the company at 25x
FY17E EPS at a premium to its only comparable peer in Asia. Wuxi
Pharmatech (the only comparable peer in Asia) is valued at ~20x FY17E
EPS. However, Syngene has superior financials compared to Wuxi
with FY15 margin of 33.0% (vs. Wuxi''s 22.3%), ROCE of 21% (vs
10.5%) and ROE of 20.7% (vs 15.2). The novel drug CMO opportunity,
could result in earnings surprise to our estimates in FY17. Further, as there are no other listed players in bio-pharm CRAMS space, we
believe Syngene will command a scarcity premium.
PavanM
273. PavanM  Aug 11, 2015 10:11
Top Contributor Top Contributor (400+ Posts, 300+ Likes)
Im unable to place sell order though i have 60 shares of Syngene. Getting "invalid data" in IIFL when trying to place a sell order. Does someone else have any clue or facing the same issue?
Prateek Jhunjhunwala
273.1. Prateek Jhunjhunwala  Aug 11, 2015 10:13
Call your broker, he may help.
The Phoenix
272. The Phoenix  Aug 11, 2015 09:47
Syngene to open @ 295
jadesmith
272.1. jadesmith  Aug 11, 2015 10:02
Didn''t get allotment in IPO, but bought at the opening @ 298.5 :)..hoping for upper circuit today.
IPO GRUP
271. IPO GRUP  Aug 10, 2015 23:42
Syngene International Ltd listing tomorow on 11/08/2015 at 9.45am bse screp coe 539268 pl noted thi note gn.
DCC
270. DCC  Aug 10, 2015 22:03
To get rich, you have to be making money while you''re asleep.

AND SYNGENE WILL WORK FOR ME WHEN I ASLEEP.

BYE FOR NOW....

DCC
269. DCC  Aug 10, 2015 21:59
APPLIED FOR TWO

ALLOTTED BOTH.

MY PLAN : HOLD FOR 2-3 YEARS , WHATEVER LISTING BUT KEEP HOLD.

THANK YOU ALL FOR ALL DETAILS/SUGGESTION/OPINIONS.
Harsh Rastogi
268. Harsh Rastogi  Aug 10, 2015 20:10
I am ready to hold Syngene stock for 2 years, can anyone tell how much will be the minimum target after 2 years?
atul
268.1. atul  Aug 10, 2015 23:14
Top Contributor Top Contributor (200+ Posts)
180 as again resession cycle starts in 2018 10year after 2008
Vivi
267. Vivi  Aug 10, 2015 20:04
72% on second day is a very good subscription.
Forum Modulator
266. Forum Modulator  Aug 10, 2015 17:12
Syngene International IPO Listing Date & Information

> Listing Date: Tuesday, August 11, 2015
> BSE Script Code: SYNGENE
> NSE Symbol: SYNGENE
> ISIN: INE398R01022
> Issue Price: Rs. 250.00 Per Equity Share
> Face Value: Rs. 10.00 Per Equity Share

Thank you,

Chittorgarh.com Forum Moderator

Forum Do''s And Don''ts (Common Sense)

  • Pls do notpostirrelevant messages or advertisements.
  • Treat ot
IPO GRUP
266.1. IPO GRUP  Aug 10, 2015 23:19
bse listing screp code keya hay??
ARVIND JANARDAN MUGAL
265. ARVIND JANARDAN MUGAL   Aug 10, 2015 13:19
Syngene will list 300+ & wii go upto 330 to 360 . Book profit around 330 & above by selling in lots of 10. Buy parent company biocon for long term 1000 + in 2-3 years.
EBERAJU
264. EBERAJU  Aug 10, 2015 12:40
Wow! 305*********************
Septa
264.1. Septa  Aug 10, 2015 15:35
IPO Guru IPO Guru (4000+ Posts, 4600+ Likes)
I got my Demat allocation on Friday itself in my icici direct also got sms NSE informing credited of syngene of share on Friday hope this help
manu
263. manu  Aug 10, 2015 12:19
hello
i have applied through icici Direct and got the allotment, money is also debited from the account but share are are not reflecting in Demat Allocation, is there any problem please help what to do.
Shripadk
263.5. Shripadk  Aug 10, 2015 18:15
Press demat allocation you will see there.
Vivi
263.6. Vivi  Aug 10, 2015 19:57
Go to Demat Allocation > Allocate > Auto Allocation of Shares.

Now Go to Portfolio > Equity > Here it is.
THE GAME
262. THE GAME  Aug 10, 2015 10:23
syngene list 305++++++++++
IPOANALYSIS
261. IPOANALYSIS  Aug 10, 2015 00:36
IPO Guru IPO Guru (1900+ Posts, 1500+ Likes)
“At present in India, we have only company : Sun Pharma Advanced research ( CMP Rs. 410 on ,Equity Rs. 23.67 crores) and accordingly it has market capitalization of Rs. 10500 crores.
In comparison, Syngene will have market capitalization of Rs. 5000 crores( at upper price band) and that brings out solid scope for rise after listing.
It is surprising that the company has left large slice, for the IPO-investors , to earn.”…In fact SPARC is a loss making company with present market cap of 9600 cr vs Syngene with net profit of 200cr fy 16E can we expect 20k-30k cr valuation in long term?
Akash, Bombay
261.1. Akash, Bombay  Aug 11, 2015 10:15
LOL ... what fantastic evaluation. Unfortunately market does not work on such simple maths
IPOANALYSIS
260. IPOANALYSIS  Aug 10, 2015 00:16
IPO Guru IPO Guru (1900+ Posts, 1500+ Likes)
Syngene provides contract drug discovery, research and manufacturing services to 17 of the world''s top 20 pharmaceutical companies, including Bristol Myers Squibb & Co and Abbott Laboratories Ltd. Its revenue rose 25 percent in the last three years.

So. considering its long term story this stock should not be sold on listing day and infact added more even those who are alloted.

It wil be above 1000 rs in 1 year.
sbs
259. sbs  Aug 9, 2015 22:14
Sorry gays my mistake i have written to morrow. Listing might be on 11/8. Regarding rate I will write on listing day.
sbs
258. sbs  Aug 9, 2015 20:20
Syngene listing to morrow. All the best to all holders
listing arround 280/- and stock go upto high 325/- & low
260/-.
IPO GRUP
258.2. IPO GRUP  Aug 9, 2015 22:02
SBS. KON MANEGA TUMARA POST JO BATARAHE HAY KE KAL LISTING HAY ABHI TAK TO LISTING KA KOI NOTICE NA HI LAGA HAY OR AAP BATARA HE HAY TOMOROW LISTING JE SAI TUMAA RATEKA BHI KESA MANE PUBLIK??/
IPO GRUP
258.3. IPO GRUP  Aug 9, 2015 22:04
THIS RIGTH DATE
Kumaripo
257. Kumaripo  Aug 9, 2015 15:48
Just a question for board members, what would u do on the listing day in syngene? Buy or sell!
Hemant Jadhav
257.1. Hemant Jadhav  Aug 9, 2015 17:26
I will hold it at least till 375







Search Chittorgarh.com:

Download Our Mobile App

Android App iOS App